CSI Market
Sign In | Register

Biohaven Ltd (BHVN) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BHVN quarterly Cash Flow →
Examining cash flow movements between Biohaven Ltd and Dec 31 2021 reveals how Dec 31 2025 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-738.82
Depreciation & amortization9.92
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation112.36
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Noncash Interest Expense-
Fair Value Adjustment Of Derivative Liability-
Interest Expense Debt Excluding Amortization-
Change In Obligation To Perform Research And Development Services-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-6.39
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities4.21
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets3.53
Other Working Capital0.00
Other Noncash Income (Expense)0.17
Other net0.00
Payments for (Proceeds from) Other Operating Activities9.43
Discontinued operations0.00
Net Cash flow from Operating Activities-609.44
Investing Activities
Capital Expenditures-0.72
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities570.00
Payments to Acquire Available-for-sale Securities, Debt-266.88
Payments for Tenant Improvements0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-1.85
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities300.56
Financing Activities
Short-term debt Net250.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock189.31
Proceeds from Contributions from Affiliates0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.19
Proceeds Sale Of Future Royalties Net Of Issuance Costs-
Proceeds From Issuance Of Common Stock Related To Sale Of Future Royalties Net Of Issuance Costs-
Pre Payment Of Second Closing Of Series Preferred Stock-
Finance Lease Principal Payments-
Proceeds From Service Obligation-
Repayment Of Long Term Debt Long Term Lease Obligation And Other-
Repayment Of Other Long Term Debt And Issuance Cost Finance Lease Payments And Other-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities439.12
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-610.15
Total Cash Flow130.24
4 historic quarters locked

Sign in to unlock the full Biohaven Ltd cash flow history.

Sign In Create Free Account

About Biohaven Ltd Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001935979-26-000020

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License